← Open Payments lookup

ALISON KALANI: Open Payments

NPI 1952740037 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$806 in 25 payments from 11 companies in 2025. Trend: 2023 $70 · 2024 $107 · 2025 $806

Food & beverage: $806
CompanyPaymentsAmount
Janssen Biotech, Inc.6$233
GENZYME CORPORATION2$119
Takeda Pharmaceuticals U.S.A., Inc.4$110
Phathom Pharmaceuticals, Inc.3$92
ABBVIE INC.3$71
Regeneron Healthcare Solutions, Inc.2$66
Madrigal Pharmaceuticals1$32
Neurocrine BioSciences, Inc.1$25
Medtronic, Inc.1$20
Novo Nordisk Inc1$20

Products named: TREMFYA, DUPIXENT, ENTYVIO, VOQUEZNA, RINVOQ, REZDIFFRA, INGREZZA, PILLCAM.

Industry payments across CO — which companies pay providers there.